Back to search results

Understanding Quality of Life with Skin Conditions in Cancer Patients

This study aims to understand how skin conditions, which are common in people with cancer or those who have had cancer treatment, affect their overall well-being. You may be able to join if you are a cancer patient or survivor, aged 3 or older, and have a skin condition related to your cancer or its treatment. Participants will complete questionnaires like Skindex-16 or DLQI (Dermatology Life Quality Index) to share how their skin condition impacts their daily life. Family members may also complete a questionnaire (FDLQI). The study hopes to improve our understanding of how these skin conditions affect quality of life. The study is currently recruiting participants.

Study design
This is an observational study planning to enroll 1025 participants. It is not a randomized or blinded study.
What's involved
You will complete one or more dermatology-specific quality of life questionnaires. If you receive treatment for your skin condition, you will complete the questionnaire again at a follow-up visit.
Compensation
Not stated in the trial record.
Follow-up
Your quality of life will be measured at 5 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02296450

Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments

Completed
Not specifiedAges 3+Observational
Memorial Sloan Kettering Cancer Center
~839 participants
Updated 2026-08-18 on ClinicalTrials.gov
What's tested:Quality of Life (QoL) Assessment

At a glance

Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Quality of Life (QoL) questionnaire
Measured over 5 years

Conditions

Cancer
Dermatologic Conditions

Explore related trials

Dermatologic ConditionsMalignant Neoplasm

Where it's being run

4 sites across 2 states
New York3
New Jersey1

Study leadership

  • Erica Lee, MD · PRINCIPAL_INVESTIGATOR · Memorial Sloan Kettering Cancer Center

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Cancer patients and survivors with a pre-existing dermatologic condition related to their underlying disease or completed/ongoing therapy for cancer, who present for assessment/management of their skin condition.
Male or female patients at least 3 years and older
NOTE: Informed Consent guidelines will be followed for minors
First grade adult family members, spouses, and caregivers of patients with a Grade 2 or 3 or higher dermatologic condition related to their primary cancer or cancer treatment able to provide written informed consent

Exclusion

Cognitive or psychiatric deficit resulting in an inability to provide written informed consent

What this trial measures

  • Quality of Life (QoL) questionnaire5 years

    in cancer patients and survivors with dermatologic conditions. This is a nontherapeutic and nondiagnostic protocol to obtain quality of life assessments from cancer patients and survivors who have dermatologic conditions, whether related to cancer therapies, or directly related to the primary cancer diagnosis. Data will be collected by using one or more dermatology-specific QoL instruments based on the underlying skin condition/s.